United Therapeutics UTHR Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is United Therapeutics's income tax?
- United Therapeutics (UTHR) reported income tax of $43.4M in Q1 2026.
- How has United Therapeutics's income tax changed year-over-year?
- United Therapeutics's income tax decreased by 57.2% year-over-year, from $101.3M to $43.4M.
- What is the long-term trend for United Therapeutics's income tax?
- Over 4 years (2021 to 2025), United Therapeutics's income tax has grown at a 33.9% compound annual growth rate (CAGR), from $118.1M to $379.2M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.